Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.

cancer genetics case-control study fine-mapping study single nucleotide polymorphism thyroid cancer

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
02 Mar 2021
Historique:
received: 14 10 2020
accepted: 26 01 2021
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 23 3 2021
Statut: epublish

Résumé

Differentiated thyroid carcinoma (DTC) incidence is characterized by wide ethnic and geographic variations, with high incidence rates observed in Oceanian populations. Genome-wide association studies (GWAS) identified mainly four DTC susceptibility loci at 9q22.33, 14q13.3, 2q35 and 8p12. Here we performed fine-mapping of the 2q35 and 8p12 loci in the population of the EPITHYR consortium that includes Europeans, Melanesians and Polynesians to identify likely causal variants for DTC risk. We conducted a colocalization analysis using eQTLs data to determine the SNPs with the highest probability of causality. At 2q35, we highlighted rs16857609 located in

Identifiants

pubmed: 33747362
doi: 10.18632/oncotarget.27888
pii: 27888
pmc: PMC7939525
doi:

Types de publication

Journal Article

Langues

eng

Pagination

493-506

Informations de copyright

Copyright: © 2021 Guibon et al.

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Références

BMC Cancer. 2017 May 12;17(1):328
pubmed: 28499365
Am J Epidemiol. 2005 Jun 1;161(11):1056-65
pubmed: 15901626
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Am J Epidemiol. 2007 Nov 15;166(10):1140-9
pubmed: 17855390
Hum Mol Genet. 2016 Sep 1;25(17):3863-3876
pubmed: 27402876
Nucleic Acids Res. 2013 Jan;41(Database issue):D177-87
pubmed: 23161675
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
Immunol Res. 2018 Dec;66(6):663-667
pubmed: 30350120
Am J Epidemiol. 2015 Aug 1;182(3):202-14
pubmed: 26133374
J Cell Sci. 2003 Feb 15;116(Pt 4):675-82
pubmed: 12538768
Nucleic Acids Res. 2018 Jan 4;46(D1):D971-D976
pubmed: 29036324
G3 (Bethesda). 2011 Nov;1(6):457-70
pubmed: 22384356
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Head Neck. 2017 Aug;39(8):1711-1718
pubmed: 28513893
Hum Mol Genet. 2010 Jun 15;19(12):2516-23
pubmed: 20350937
Int J Cancer. 2019 Feb 1;144(3):503-512
pubmed: 30350351
Am J Hum Genet. 2016 Apr 7;98(4):653-66
pubmed: 27018471
Cancer Causes Control. 2009 Jul;20(5):581-90
pubmed: 19043789
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
pubmed: 23535729
Nature. 2014 Mar 27;507(7493):455-461
pubmed: 24670763
Nat Rev Genet. 2005 Apr;6(4):333-40
pubmed: 15803201
Nat Commun. 2017 Feb 14;8:14517
pubmed: 28195142
Cancer Causes Control. 2015 Apr;26(4):511-8
pubmed: 25754110
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1369-1379
pubmed: 29121253
J Clin Endocrinol Metab. 2014 Oct;99(10):E2084-92
pubmed: 25029422
Eur Thyroid J. 2014 Sep;3(3):189-96
pubmed: 25538901
Genome Med. 2014 Oct 31;6(10):91
pubmed: 25473427
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
Cancer Epidemiol. 2017 Jun;48:78-84
pubmed: 28426980
Int J Cancer. 2010 Jun 15;126(12):2984-90
pubmed: 19950225
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
J Clin Endocrinol Metab. 2013 Oct;98(10):E1674-81
pubmed: 23894154
Mol Genet Genomic Med. 2015 Aug 09;4(1):18-27
pubmed: 26788534
Int J Cancer. 2021 Jun 15;148(12):2935-2946
pubmed: 33527407
Eur J Cancer Prev. 2007 Feb;16(1):62-70
pubmed: 17220706
Radiat Res. 2004 Apr;161(4):481-92
pubmed: 15038762
Nature. 2016 Oct 13;538(7624):201-206
pubmed: 27654912
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Int J Cancer. 2016 Aug 1;139(3):617-27
pubmed: 26991144
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
J Clin Endocrinol Metab. 2005 Oct;90(10):5747-53
pubmed: 16030170
Nat Commun. 2017 Jul 13;8:15966
pubmed: 28703219
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2009 Apr;41(4):460-4
pubmed: 19198613
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
Cancer Lett. 2003 Mar 10;191(2):193-202
pubmed: 12618333
Nat Genet. 2012 Jan 22;44(3):319-22
pubmed: 22267200
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987

Auteurs

Julie Guibon (J)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.
Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.

Pierre-Emmanuel Sugier (PE)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.

Om Kulkarni (O)

University Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.

Mojgan Karimi (M)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.

Delphine Bacq-Daian (D)

University Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.

Céline Besse (C)

University Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.

Anne Boland (A)

University Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.

Elisabeth Adjadj (E)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Epidemiology of Radiations Team, Villejuif, France.

Frédérique Rachédi (F)

Endocrinology Unit, Territorial Hospital Taaone, Papeete, French Polynesia.

Carole Rubino (C)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Epidemiology of Radiations Team, Villejuif, France.

Constance Xhaard (C)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Epidemiology of Radiations Team, Villejuif, France.
University of Lorraine, INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, Nancy, France.

Claire Mulot (C)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France.

Pierre Laurent-Puig (P)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France.

Anne-Valérie Guizard (AV)

Registre Général des Tumeurs du Calvados, Centre François Baclesse, Caen, France.
Inserm U1086 -UCN "ANTICIPE", Caen, France.

Claire Schvartz (C)

Registre des Cancers Thyroïdiens, Institut Godinot, Reims, France.

Rosa Maria Ortiz (RM)

Institute of Oncology and Radiobiology, La Havana, Cuba.

Yan Ren (Y)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Epidemiology of Radiations Team, Villejuif, France.

Evgenia Ostroumova (E)

International Agency for Research on Cancer, Lyon, France.

Jean-François Deleuze (JF)

University Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.

Marie-Christine Boutron-Ruault (MC)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.

Ausrele Kesminiene (A)

International Agency for Research on Cancer, Lyon, France.

Florent De Vathaire (F)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Epidemiology of Radiations Team, Villejuif, France.

Pascal Guénel (P)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.

Fabienne Lesueur (F)

Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
These authors contributed equally to this work.

Thérèse Truong (T)

University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Exposome and Heredity Team, Villejuif, France.
These authors contributed equally to this work.

Classifications MeSH